A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61K 39/395 (2006.01)
Patent
CA 2714335
The present invention relates to methods for treating multiple sclerosis by administering therapeutically effective amounts of an alpha-fetoprotein polypeptide (or a biologically active fragment, derivative, or analog thereof) and an integrin antagonist (e.g., natalizumab) to a patient in need thereof. Also disclosed are compositions and kits that comprise therapeutically effective amounts of an alpha- fetoprotein polypeptide (or a biologically active fragment, derivative, or analog thereof) and an integrin antagonist (e.g., natalizumab).
La présente invention concerne des méthodes destinées au traitement de la sclérose en plaques, comprenant l'administration de doses thérapeutiques d'un polypeptide d'alpha-foetoprotéine (ou d'un fragment, dérivé ou analogue biologiquement actif de celui-ci) et d'un antagoniste de l'intégrine (le natalizumab, par exemple) à un patient nécessitant un traitement de ce type. L'invention concerne également des compositions et des trousses comprenant des doses thérapeutiques d'un polypeptide d'alpha-foetoprotéine (ou d'un fragment, dérivé ou analogue biologiquement actif de celui-ci) et d'un antagoniste de l'intégrine (le natalizumab, par exemple).
Briskin Michael
Stewart Edward J.
Merrimack Pharmaceuticals Inc.
Osler Hoskin & Harcourt Llp
LandOfFree
Methods of treating multiple sclerosis by administration of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating multiple sclerosis by administration of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating multiple sclerosis by administration of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1646733